Delivery Order SPE2DB22D3501-SPE2DB25FVV73
Award Date
5/28/25
Potential Completion Date
6/18/25
Potential Value
$7.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of NovoSeven RT 5 mg vials, a medication used to treat hemophilia. The contract has a ceiling value of $34,556.45 and runs through July 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $27,604.30 order is for the supply of NOVOSEVEN RT 2 MG VIALS, a specialized pharmaceutical product. The delivery order is part of Amerisourcebergen's existing indefinite delivery contract with DLA to provide pharmaceuticals and medical supplies in support of military treatment programs and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 2 mg vials of the medication NovoSeven RT, with a ceiling value of $2,760.43 and an ultimate completion date of December 2, 2024. The contract is a firm fixed-price delivery order, and there is no set-aside designation, indicating open competition. AmerisourceBergen holds a large...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NovoSeven RT 5 mg vials. The contract, valued at $6,911.29, is a firm fixed-price delivery order with an ultimate completion date of September 12, 2024. There is no set-aside designation for this award. Amerisourcebergen, through its Corporate Office division, will provide this critical medication to support various federal healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,750.80 firm fixed-price delivery order is for the supply of 4,566,658,071 units of the medication NovoSeven RT 5 mg vials. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award is for the delivery of 2 mg vials of the blood clotting medication NOVOSEVEN RT to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor for this $5,520.86 firm-fixed-price delivery order is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 2025....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $82,935.48 firm-fixed-price contract is for the supply of NovoSeven RT 5 mg vials, a pharmaceutical product. The contract has an ultimate completion date of August 5, 2024. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $50,818.95, is for the supply of NovoSeven RT 5 mg vials, a specialty pharmaceutical product. The contract has an ultimate completion date of March 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,900.96 Firm Fixed Price delivery order contract is for the supply of NovoSeven RT 5 mg vials, a specialty medication. The contract has an ultimate completion date of December 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,846.64 firm fixed-price delivery order is for the supply of NovoSeven RT 2 mg vials, a specialty medication. This award is a part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...